Our Policy Priorities
Because ignoring the pain and disability of arthritis is unacceptable, the Arthritis Foundation is working to conquer this debilitating disease and make a positive impact on the lives of people with arthritis. Follow the links below to find more information on our advocacy priorities and sample letters you can send to your Members of Congress urging them to step forward and take action on these important issues. Download the one-page summary of our advocacy priorities.
Access to Care
- Priority: End Discrimination Against Specialty Tier Medications
- Priority: Increase Access to Pediatric Rheumatologists
Research & Prevention
- Priority: Fund Arthritis Research at the Department of Defense
- Priority: Support Arthritis Research at the National Institutes of Health
- Priority: Increase Funding of Arthritis Prevention at the Centers for Disease Control
- Priority: Build a strong Congressional Arthritis Caucus
- Priority: Make arthritis a national priority
This list in no way encompasses all of the areas for legislative action. That's why we welcome your ideas for enhancing the arthritis advocacy agenda. Send your thoughts to email@example.com.
AF Board of Directors Position Statements
- Read the Arthritis Foundation position statement on Biosimilars passed on July 20, 2013.
- Read the Arthritis Foundation position statement on excessive cost sharing (specialty tiers) for high cost medication. The statement was passed on November 19, 2011.
Arthritis Foundation Appropriation Requests
Our 2013 Accomplishments
OA Agenda - A National Public Health Agenda for Osteoarthritis. Read more.
- Latest State Prevalence Data Released from the Centers for Disease Control and Prevention. Learn How Many In Your State Live With Arthritis.
- New Data Shows Arthritis Impact Worse Among Minorities. Read the Report Summary.
The Advocacy and Access team is based in downtown Washington, DC. To contact the department, please see the below information:Arthritis Foundation Department of Advocacy and Access
1615 L St., NW, Suite 320